N. R. Gandhi, P. Nunn, K. Dheda, H. S. Schaaf, M. Zignol et al., Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis, The Lancet, vol.375, issue.10, pp.60410-60412, 2010.

, World Health Organization, 2015.

C. Dye and M. A. Espinal, Will tuberculosis become resistant to all antibiotics?, Proc Biol Sci, vol.268, pp.45-52, 2001.

E. C. Böttger and B. Springer, Tuberculosis: drug resistance, fitness, and strategies for global control, Eur J Pediatr, vol.167, p.17987316, 2008.

U. R. Dahle, P. Sandven, E. Heldal, T. Mannsaaker, and D. A. Caugant, Deciphering an Outbreak of Drug-Resistant Mycobacterium tuberculosis, J ClinMicrobiol, vol.41, pp.67-72, 2003.

H. Mardassi, A. Namouchi, R. Haltiti, M. Zarrouk, B. Mhenni et al., Tuberculosis due to Resistant Haarlem Strain, Tunisia. Emerg Infect Dis, vol.11, pp.957-961, 2005.
URL : https://hal.archives-ouvertes.fr/pasteur-00874087

A. Van-rie, R. M. Warren, N. Beyers, R. P. Gie, C. N. Classen et al., Transmission of a multidrug-resistant Mycobacterium tuberculosis strain resembling "strain W" among noninstitutionalized, human immunodeficiency virus-seronegative patients, J Infect Dis, vol.180, pp.1608-1615, 1999.

S. Gagneux, K. Deriemer, T. Van, M. Kato-maeda, B. C. De-jong et al., Variable host-pathogen compatibility in Mycobacterium tuberculosis, Proc Natl AcadSci U S A, vol.103, pp.2869-2873, 2006.

S. Borrell and S. Gagneux, Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis

, Int J Tuberc Lung Dis, vol.13, pp.1456-1466, 2009.

S. Borrell and S. Gagneux, Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis, ClinMicrobiol Infect Off PublEurSocClinMicrobiol Infect Dis, vol.17, 2011.

O. J. Billington, T. D. Mchugh, and S. H. Gillespie, Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis, Antimicrob Agents Chemother, vol.43, p.10428904, 1999.

P. Sander, B. Springer, T. Prammananan, A. Sturmfels, M. Kappler et al., Fitness cost of chromosomal drug resistance-conferring mutations, Antimicrob Agents Chemother, vol.46, p.11959546, 2002.

I. Comas, S. Borrell, A. Roetzer, G. Rose, B. Malla et al., Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes, Nat Genet, vol.44, pp.106-110, 2012.

, World Health Organization. Definitions and reporting framework for tuberculosis-2013 revision, 2013.

J. Kamerbeek, L. Schouls, A. Kolk, M. Van-agterveld, D. Van-soolingen et al., Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology, J ClinMicrobiol, vol.35, pp.907-914, 1997.

P. Supply, C. Allix, S. Lesjean, M. Cardoso-oelemann, S. Rüsch-gerdes et al., Proposal for Standardization of Optimized Mycobacterial Interspersed Repetitive Unit-Variable-Number Tandem Repeat Typing of Mycobacterium tuberculosis, J ClinMicrobiol, vol.44, pp.4498-4510, 2006.

A. Namouchi, R. Haltiti, D. Hawari, and H. Mardassi, Re-emergence of the progenitors of a multidrug-resistant outbreak strain of Mycobacterium tuberculosis among the post-outbreak case patients, J Infect Dis, vol.201, pp.390-398, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-00621010

A. Sandgren, M. Strong, P. Muthukrishnan, B. K. Weiner, G. M. Church et al., Tuberculosis Drug Resistance Mutation Database, PLoS Med, vol.6, p.1000002, 2009.

A. H. Mokdad, S. Jaber, M. Aziz, F. Albuhairan, A. Alghaithi et al., The state of health in the Arab world, 1990-2010: an analysis of the burden of diseases, injuries, and risk factors, Lancet Lond Engl, vol.383, issue.13, pp.62189-62192, 2014.

V. Ritacco, M. D. Lonardo, A. Reniero, M. Ambroggi, L. Barrera et al., Nosocomial Spread of Human Immunodeficiency Virus-Related Multidrug-Resistant Tuberculosis in Buenos Aires, J Infect Dis, vol.176, pp.637-642, 1997.

D. Palmero, V. Ritacco, M. Ambroggi, M. Natiello, L. Barrera et al., Multidrug-Resistant Tuberculosis in HIV-Negative Patients, Emerg Infect Dis, vol.9, pp.965-969, 2003.

V. Eldholm, J. Monteserin, A. Rieux, B. Lopez, B. Sobkowiak et al., Four decades of transmission of a multidrug-resistant Mycobacterium tuberculosis outbreak strain, Nat Commun, vol.6, p.7119, 2015.

S. Suchindran, E. S. Brouwer, and A. Van-rie, Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review, PloS One, vol.4, p.5561, 2009.

A. Namouchi, A. Karboul, B. Mhenni, N. Khabouchi, R. Haltiti et al., Genetic profiling of Mycobacterium tuberculosis in Tunisia: predominance and evidence for the establishment of a few genotypes, J Med Microbiol, vol.57, pp.864-872, 2008.
URL : https://hal.archives-ouvertes.fr/pasteur-00871799

N. Meftahi, A. Namouchi, B. Mhenni, G. Brandis, D. Hughes et al., Evidence for the critical role of a secondary site rpoB mutation in the compensatory evolution and successful transmission of an MDR tuberculosis outbreak strain, J AntimicrobChemother, vol.71, pp.324-332, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01374988

K. Stoffels, V. Mathys, M. Fauville-dufaux, R. Wintjens, and P. Bifani, Systematic analysis of pyrazinamideresistant spontaneous mutants and clinical isolates of Mycobacterium tuberculosis, Antimicrob Agents Chemother, vol.56, pp.5186-5193, 2012.

N. Casali, V. Nikolayevskyy, Y. Balabanova, S. R. Harris, O. Ignatyeva et al., Evolution and transmission of drug resistant tuberculosis in a Russian population, Nat Genet, vol.46, p.24464101, 2014.

P. Miotto, A. M. Cabibbe, S. Feuerriegel, N. Casali, F. Drobniewski et al., Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study, mBio, vol.5, p.25336456, 2014.

A. L. Den-hertog, S. Sengstake, and R. M. Anthony, Pyrazinamide resistance in Mycobacterium tuberculosis fails to bite? Pathog Dis, vol.73, p.25994506, 2015.

A. Alito, N. Morcillo, S. Scipioni, A. Dolmann, M. I. Romano et al., The IS6110 restriction fragment length polymorphism in particular multidrug-resistant Mycobacterium tuberculosis strains may evolve too fast for reliable use in outbreak investigation, J Clin Microbiol, vol.37, p.9986855, 1999.

P. Farnia, M. R. Masjedi, B. Nasiri, M. Mirsaedi, S. Sorooch et al., Instability of IS6110 patterns in multidrug-resistant strains of Mycobacterium tuberculosis, Epidemiol Infect, vol.135, pp.346-352, 2007.

C. B. Ford, R. R. Shah, M. K. Maeda, S. Gagneux, M. B. Murray et al., Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis, Nat Genet, vol.45, p.23749189, 2013.

D. J. Palmero, M. Ambroggi, A. Brea, D. Lucas, M. Fulgenzi et al., Treatment and follow-up of HIV-negative multidrug-resistant tuberculosis patients in an infectious diseases reference hospital, Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis, vol.8, pp.778-784, 2004.

J. C. Johnston, N. C. Shahidi, M. Sadatsafavi, and J. M. Fitzgerald, Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis, PloS One, vol.4, p.6914, 2009.

P. Weiss, W. Chen, V. J. Cook, and J. C. Johnston, Treatment outcomes from community-based drug resistant tuberculosis treatment programs: a systematic review and meta-analysis, BMC Infect Dis, vol.14, p.333, 2014.

D. Meressa, R. M. Hurtado, J. R. Andrews, E. Diro, K. Abato et al., Achieving high treatment success for multidrug-resistant TB in Africa: initiation and scale-up of MDR TB care in Ethiopia-an observational cohort study, Thorax, vol.70, pp.1181-1188, 2015.